Perceptive Advisors LLC Singular Genomics Systems, Inc. Transaction History

Perceptive Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.58 $77,985 - $137,066	-236,321 Reduced 10.0%	2,126,893 $978,000
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.28 $716,867 - $1.18 Million	-919,061 Reduced 28.0%	2,363,214 $1.96 Million
Q4 2022 Feb 14, 2023	SELL	$1.82 - $2.71 $462,278 - $688,337	-253,999 Reduced 7.18%	3,282,275 $6.6 Million
Q2 2022 Aug 15, 2022	SELL	$2.86 - $6.44 $340,148 - $765,928	-118,933 Reduced 3.25%	3,536,274 $13.5 Million
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $1.91 Million - $3.89 Million	321,383 Added 9.64%	3,655,207 $23.1 Million
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $2.72 Million - $4.39 Million	260,000 Added 8.46%	3,333,824 $38.5 Million
Q3 2021 Nov 15, 2021	SELL	$10.9 - $27.63 $98,601 - $249,940	-9,046 Reduced 0.29%	3,073,824 $34.4 Million
Q2 2021 Aug 16, 2021	BUY	$23.16 - $31.17 $71.4 Million - $96.1 Million	3,082,870 New	3,082,870 $84.7 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.1B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.